Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes

Acta Diabetol. 2014;51(3):517-8. doi: 10.1007/s00592-013-0512-8. Epub 2013 Sep 5.

Authors

Stephanie Krause¹, Andreas Beyerlein, Christiane Winkler, Anita Gavrisan, Christiane Kayser, Ramona Puff, Ezio Bonifacio, Anette-Gabriele Ziegler, Peter Achenbach

Affiliation

¹ Institute of Diabetes Research, Helmholtz Zentrum München, Ingolstaedter Landstr. 1, 85764, Neuherberg, Germany.

PMID: 24006086
DOI: 10.1007/s00592-013-0512-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Autoantibodies / immunology
Case-Control Studies
Child
Cohort Studies
Diabetes Mellitus, Type 1 / blood
Diabetes Mellitus, Type 1 / genetics
Diabetes Mellitus, Type 1 / immunology*
Female
Humans
Interleukin-2 Receptor alpha Subunit / blood
Interleukin-2 Receptor alpha Subunit / genetics
Interleukin-2 Receptor alpha Subunit / immunology*
Islets of Langerhans / immunology
Male
T-Lymphocytes / immunology

Substances

Autoantibodies
Interleukin-2 Receptor alpha Subunit